Migraine
For participants ages 18-65 to evaluate the efficacy, safety and tolerability of a single dose of study medication in the acute treatment of migraines. There are a total of 3 study visits and you will be compensated for your time.
 
Migraine
 

For participants ages 18-65 to evaluate the efficacy, safety and tolerability of a single dose of study medication in the acute treatment of migraines.  There are a total of 3 study visits and you will be compensated for your time. 

 
go back
Register
Get Started Today!
Fill out my online form.